- Are we justified to classify patients with two unrelated clones with del(5q) and trisomy 8 as a subgroup of myelodysplastic syndrome of the type of 5q-syndrome?2014 | First Faculty of Medicine
- Deletion of 5q in hematological malignanciesPublication without faculty affiliation
- Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q)Publication without faculty affiliation
- Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome2011 | First Faculty of Medicine
- News in the pathogenesis of two subtypes of myelodysplastic syndrome: 5q minus syndrome and Sideroblastic anemia, partly valid in other hematooncological diseases.2012 | First Faculty of Medicine
- Regulation of megakaryocytopoiesis, Fli1 transcription factor and its importance in 5q minus syndrome2013 | Publication without faculty affiliation
- TP53 mutations in myelodysplastic syndrome is significantly correlated with deletion of the long arm 5.chromozomu (5q-) and usually has a negative prognostic value (meaning TP53 examination in the era of lenalidomide)2013 | First Faculty of Medicine
- Case report: (non)chelated, poly-transfused patient with 5q minus syndrome2015 | First Faculty of Medicine
- Changes associated with lenalidomide treatment in the gene expression profiles of patients with Del(5q)2012 | First Faculty of Medicine
- Analysis of myelodysplastic syndrome patients with deletion of long arm chromosome 5 followed up by the Czech MDS Working Group. Significance for the diagnostic and prognostic assessment2009 | Faculty of Medicine in Hradec Králové
- Analysis of myelodysplastic syndrome patients with deletion of long arm chromosome 5 followed up by the Czech MDS Working Group. Significance for the diagnostic and prognostic assessment2009 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Analysis of myelodysplastic syndrome patients with deletion of long arm chromosome 5 followed up by the Czech MDS Working Group. Significance for the diagnostic and prognostic assessment2009 | First Faculty of Medicine
- Analysis of myelodysplastic syndrome patients with deletion of long arm of chromosome 5 followed up by the Czech MDS Working Group. Significance for the diagnostic and prognostic assessment2009 | First Faculty of Medicine
- Lenalidomide treatment of patients with 5q- syndrome affects genes located in the TNF pathwayPublication without faculty affiliation
- Analysis of interstitial deletions of 5q in myeloid malignancies and its correlation with clinical markersPublication without faculty affiliation
- Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion2018 | Publication without faculty affiliation
- Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide2015 | First Faculty of Medicine
- Combination of molecular cytogenetic techniques in mapping of the atypical 5q deletion in myeloid malignanciesPublication without faculty affiliation
- Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and Intermediate-1)Publication without faculty affiliation
- Co víme o buněčných mechanismech vedoucích k efektu lenalidomidu u MDS s 5q-2016 | First Faculty of Medicine
- Retrospective study of deletions of 5q in patients with myelodysplastic syndrome (MDS) or acute maeloid leukemia (AML)Publication without faculty affiliation
- Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment2015 | First Faculty of Medicine
- The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatmentPublication without faculty affiliation
- Lenalidomide treatment in myelodysplastic syndrome with 5q deletion - Czech MDS group experience2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide2015 | Faculty of Science
- Changes in Gene Expression Profiles in Patients with 5q- Syndrome Caused by Lenalidomide TreatmentPublication without faculty affiliation
- Klinický význam rozsahu del(5q) u nemocných s MDS2021 | First Faculty of Medicine, Central Library of Charles University
- Multicolor banding fluorescence in situ hybridization technique in the evaluation of 5q deletionsPublication without faculty affiliation
- Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies2000 | Publication without faculty affiliation
- Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents2016 | First Faculty of Medicine